VGXI

VGXI is live at Advanced Therapies UK! With the spotlight on Associate Director, Michelle Stretz. Exciting discussions are taking place around the future of gene and cell therapy, and VGXI is proud to contribute to the innovation shaping high-quality plasmid DNA manufacturing. Looking forward to engaging with industry leaders and exploring new opportunities in biotech and advanced therapies. #VGXI #AdvancedTherapies #Biotech #GeneTherapy #CellTherapy #PlasmidDNA #LifeSciences #Biopharma #Networking

While luck has its place, real progress is built on expertise, precision, and the right partnerships. Here’s to the science, the strategy, and a little bit of Irish luck along the way! Happy St. Patrick's Day! #VGXI #PlasmidDNA #Biotech #GeneTherapy #Manufacturing

Innovation starts with collaboration—meet VGXI at BPI West! We’re heading to BioProcess International US West in San Diego, March 18-21 to discuss the latest advancements in plasmid DNA manufacturing and bioprocessing solutions. Let’s connect and drive the future of biopharmaceutical innovation together. Learn more: https://lnkd.in/gybS7bxX #BPIWest #Bioprocessing #VGXI #Biotech #LifeSciences #SanDiego

Stability fuels progress. In biopharma, the reliability of breakthrough therapies hinges on the consistency of their foundational components—including plasmid DNA. In our latest white paper, "Stability of Plasmid DNA Products: A Review of the Data," we dive deep into the science behind plasmid DNA stability and its impact on the success of gene and cell therapies. Understanding these insights is key to driving innovation and ensuring patient safety. Be at the forefront of discovery. Download the white paper today: https://lnkd.in/dwJtFSnx #VGXI #BiopharmaInnovation #PlasmidDNA #GeneTherapy #CellTherapy #IndustryInsights #StabilityMatters #WhitePaper

Good DNA manufacturing doesn’t just happen—it’s engineered. Let’s build it right. The 2nd DNA Process Development & Manufacturing Summit is where innovation meets precision. As gene and cell therapies advance, the demand for high-quality DNA manufacturing grows. This summit will address critical challenges in scalability, regulatory alignment, and next-generation production techniques. Join the discussion in Boston, March 26-27, 2025. Meet Matt Fisichelli, Business Development Manager, at the event to explore how we can advance DNA manufacturing together. Learn more: https://lnkd.in/gitkNQ2M #DNAManufacturing #GeneTherapy #Biotech #PlasmidDNA #Biopharma #FutureOfMedicine

Exciting News! VGXI is heading to London! Advanced therapies are shaping the future of healthcare, and VGXI is proud to be part of the conversation at Advanced Therapies 2025 in ExCeL, London, on March 18-19. Let’s connect. If you're attending, don’t miss the chance to discuss how VGXI’s industry-leading plasmid DNA manufacturing solutions can support your advanced therapy goals. Schedule a meeting with us today: https://lnkd.in/gZK5bvig #AdvancedTherapies #Biotech #CellTherapy #GeneTherapy #VGXI #LifeSciences #Pharma #HealthcareInnovation #LondonEvents

The race is on—your plasmid DNA partner can make all the difference. In AAV gene therapy, challenges like ITR instability, low yields, and scalability issues can delay critical treatments. The right plasmid manufacturer ensures your therapy moves forward without setbacks. At VGXI, we eliminate these roadblocks with...To learn more: https://lnkd.in/grAYhvCu #GeneTherapy #AAV #PlasmidManufacturing #VGXI #BiotechInnovation

The future of biopharma depends on stability—of data, of innovation, and of the critical materials that power breakthrough therapies. In our latest white paper "Stability of Plasmid DNA Products: A Review of the Data" we explore the critical role of plasmid DNA stability in ensuring the reliability and effectiveness of gene and cell therapies. Be among the first to explore the data and stay ahead of the curve. Access the White Paper: https://lnkd.in/dwJtFSnx #VGXI #ThoughtLeadership #WhitePapers #Biopharma #PlasmidDNA #GeneTherapy #Innovation #IndustryInsights

Texas Resilience, Texas Spirit—Standing with the Rare Disease Community On Go Texas Day, we celebrate resilience, strength, and community—the same qualities that define the 300 million people worldwide living with a rare disease. With over 6,000 identified rare diseases, awareness fuels action, and action drives progress. This Rare Disease Day, let’s stand together to advance research, innovation, and support for those who need it most. Texans don’t just face challenges—we rise to meet them. Let’s make an impact. Learn more at RareDiseaseDay.org and be part of the movement. #GoTexasDay #RareDiseaseDay #TexasStrong #HealthcareInnovation #Advocacy

Unlock the Power of High-Quality Plasmid Manufacturing Bringing life-changing therapies to patients starts with a strong foundation—high-quality, cGMP-compliant plasmid DNA. At VGXI, we provide industry-leading plasmid manufacturing solutions to support gene and cell therapies, vaccines, and immunotherapies at every stage. Our newly enhanced Product & Services Catalog is designed to help you quickly explore our service levels, advanced analytical capabilities, and proven expertise. Ready to take your project to the next level? Download the catalog today: https://lnkd.in/g5pYVAtK #VGXI #PlasmidDNA #GeneTherapy #Biotech #CellTherapy #cGMP #Biomanufacturing #Innovation